Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Karo Pharma: Interim report H1 2022


News provided by

Karo Pharma

21 Jul, 2022, 06:23 GMT

Share this article

Share toX

Share this article

Share toX

HUDDINGE, Sweden, July 21, 2022 /PRNewswire/ -- 

January – June          

  • Revenues amounted to MSEK 1 965.3 (1 460.9), corresponding to an increase of +35% for the period.          
  • The organic growth1 during the period was +6%. The currency impact was +3% while the acquisitions of the Sylphar Group and E45® brand portfolio from Reckitt generated growth of +26%.          
  • EBIT (Operating Profit) amounted to MSEK 3.8 (159.1), corresponding to a decline of 98%.          
  • EBITDA1 amounted to MSEK 394.6 (440.4) corresponding to a decline of 10%. Adjusted for non-recurring transactional cost of 92.0 MSEK directly related to the acquisitions of new business combinations the EBITDA1 would be MSEK 486.6 equal to an increase of 10%.          
  • The gross margin, defined as gross profit divided by revenues, was 56.6% (58.6%) for the period. The margin was affected negatively by mix effects from the acquisitions.         
  • Cash flow from operating activities amounted to MSEK 146.2 (172.1). Adjusted for non-recurring transactional costs mentioned above, the Cash flow from operating activities would be MSEK 238.2.          
  • Earnings per share was SEK -0.56 (0.14), before and after dilution.

1 Alternative Performance Measures (APM),
see notes for further information.

Comments by CEO Christoffer Lorenzen

Karo continues to grow at a fast pace and to develop as a business and organization. In the first half of 2022 we executed according to the objectives for the year laid out in the 2021 Annual Report. Specifically, we have integrated acquired businesses, expanded our geographic footprint, and accelerated investments into people, (digital) competencies and brand activation. We have also lifted the organic growth rate from Karo's existing businesses.

The first half of 2022 saw revenue growth of 35% vs. the year prior, driven by the additions of the acquired businesses, Sylphar and the E45 brand. About 15% of sales are now generated by our so-called digital-first portfolio of brands. The organic growth came in at 6% in difficult consumer markets.

Through H1, Karo has continued to demonstrate resilience and robustness in a rapidly changing and volatile business environment: Karo's delivery performance (service level) is sustained at levels above 98% despite supply chain disruptions, which have adversely impacted many international businesses. Simultaneously, Karo's gross margins have, when adjusting for the mix effect from recent acquisitions, increased compared to the year prior. This reflects that we have successfully absorbed and responded to cost increases from our suppliers related to raw materials and energy cost increases by increasing our outbound price points. The decrease in reported gross margin is the result of the acquisitions, which have increased logistics costs, specifically approx. MSEK 100 in costs related to Amazon's logistics services, FBA (fulfilment by Amazon). 

H1 saw high levels of activity related to M&A transactions and our corporate finance agenda, which resulted in non-recurring, one-off costs that were not related to ordinary course of business of just below MSEK 100. These costs distort the reported financials related to our core metrics, EBITDA and cash flow. When normalizing for them, our adjusted EBITDA grew 10%. 

Highlights from H1 include:           

  • The Sylphar business acquisition closed on January 13. The Sylphar business has been integrated and a new organization put in place that leverages Sylphar's entrepreneurial strengths within digital marketing and digital commerce to drive organic growth across the entire Karo portfolio of brands.           
  • E45 transaction closed on April 1. Take-over of the brand from Reckitt is running according to plan with first commercial markets going live on July 1 (including Spain and South Africa).           
  • Fully subscribed rights issue of MEUR 250 completed securing financing of Karo's recent acquisitions; change of listing venue to Nasdaq First North completed on March 23.           
  • ESG targets released in connection with the 2021 Annual Report, setting a clear and ambitious agenda for Karo's continued development at the forefront of the important sustainability agenda.           
  • Direct commercial organization established in Spain, expanding Karo's footprint to one more EU M5 market.           
  • Continued development of Karo's commercial organization with a step-up in A&P investments and investments into digital commerce and digital assets.           
  • The Karo organization remains highly engaged with eNPS scores increasing to 60 in June '22 (compared to 52 in June '21).           
  • As a response to the war in Ukraine, Karo donated pain killers (1.6m doses of paracetamol and ibuprofen) and hand sanitizers (Decubal Hand Wash and DAX Alcogel) to serve specific needs at Ukrainian hospitals and emergency units. The donations are a result of collaboration with global aid NGOs and the Swedish authorities and serve as a testament of the relevance of Karo's brand portfolio in serving important healthcare needs.

With the above moves we are a step closer to delivering on our promise of creating a highly efficient, leading European platform in everyday healthcare!

Christoffer Lorenzen
CEO 

Significant events after period end
Nothing to report. 

Financial calendar

Year-end report 2022           Feb 22, 2023

The Annual Report 2021 was released April 12, 2022 and the Annual General Meeting was held May 31, 2022.

Contact

Christoffer Lorenzen, CEO

Jon Johnsson, CFO                                               

+46 73-501 76 20

+46 73-507 88 61                                               

christoffer.lorenzen@karopharma.com 

jon.johnsson@karopharma.com                                   

About Karo Pharma

Karo Pharma offers "Smart choices for everyday healthcare". We own and commercialize reliable original brands within prescription drugs and over over-the-counter consumer products. Our products are available in over 90 countries with the core in Europe and the Nordics region. The headquarter of Karo Pharma is in Stockholm and the company is listed on Nasdaq First North Growth Market.
 
This information is information that Karo Pharma AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on July 21, 2022, at 08.00 CET.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/karo-pharma/r/interim-report-h1-2022,c3603764

The following files are available for download:

https://mb.cision.com/Main/72/3603764/1606328.pdf

INTERIM REPORT JANUARY â€" JUNE 2022 (PDF)

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.